Does MK-677 Require PCT? Cycling and Post-Cycle Guide

Medically Reviewed ✅
Last Updated February 10, 2026
Mk-677 cycling and PCT

Want the latest research on peptides delivered to your inbox? Join our daily All About Peptides newsletter for weekly insights backed by clinical studies—not marketing hype.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before considering any peptide therapy.

MK-677, also known as ibutamoren, operates differently than anabolic steroids and selective androgen receptor modulators. While most performance compounds suppress natural hormone production and require post-cycle therapy to restore balance, MK-677 does not shut down the hypothalamic-pituitary-gonadal (HPG) axis. You can stop using it without experiencing the hormonal crash typical of suppressive compounds.

MK-677 acts as a ghrelin receptor agonist, stimulating your body’s natural growth hormone production rather than replacing it with external hormones. Clinical trials lasting 12 to 24 months show sustained increases in growth hormone and insulin-like growth factor-1 (IGF-1), with levels returning to baseline within weeks of stopping.

Quick Takeaways

  • MK-677 does not suppress testosterone production, so traditional PCT drugs like Clomid or Nolvadex are unnecessary
  • Typical cycles last 8 to 20 weeks, followed by 4 to 6 weeks off to support insulin sensitivity
  • Growth hormone and IGF-1 return to baseline within a few weeks after discontinuation
  • Off-cycle strategies focus on metabolic health rather than hormonal recovery

How MK-677 Works Differently Than Steroids

MK-677 increases growth hormone secretion through ghrelin receptor activation rather than androgen receptor binding. This mechanism explains why post-cycle requirements for MK-677 differ so sharply from anabolic compounds.

Ghrelin Receptor Activity

When MK-677 binds to ghrelin receptors, it signals the pituitary gland to increase natural growth hormone release.

In a double-blind study, a single dose produced peak GH responses of 55.9 μg/L, compared to 9 μg/L with placebo. Secretion remains pulsatile, preserving normal feedback regulation.

This mechanism does not interfere with gonadotropin signaling. Luteinizing hormone and follicle-stimulating hormone levels remain stable. Testosterone production continues uninterrupted during and after use.

IGF-1 Elevation and Anabolic Effects

Increased growth hormone output leads to consistent elevations in IGF-1. Human research shows that these levels rise from approximately 188 ng/mL at baseline to 264 ng/mL during treatment.

No evidence of tolerance appears under standard dosing protocols.

IGF-1 promotes protein synthesis, nitrogen retention, and cellular anabolism across multiple tissues. MK-677 also increases intracellular water content, reflecting increases in body cell mass rather than superficial fluid retention.


Third-Party Tested, 99% Purity

Order lab-verified peptides from our top recommended vendor.


MK-677 Cycling Protocols

Because MK-677 does not suppress natural hormones, cycling focuses on metabolic optimization rather than endocrine recovery. Most users employ structured on-and-off periods to preserve insulin sensitivity and responsiveness.

Recommended Cycle Lengths

Cycles between 8 and 12 weeks work well for body recomposition and recovery.

In a landmark 12-month trial involving 65 healthy older adults, daily 25 mg dosing increased fat-free mass by 1.1 kg. The placebo group lost 0.5 kg. Lean mass gains appeared within the first 8-12 weeks and continued with prolonged use.

Longer cycles of 16-20 weeks may be useful for extended recovery or tissue-healing protocols. Human data support continuous administration for up to 24 months, though periodic breaks remain prudent.

Dosing Strategies and Timing

Clinical evidence supports a daily dose range of 10-25 mg.

Lower doses around 10-15 mg favor sleep and recovery. Doses of 15-25 mg produce more pronounced effects on lean mass and training adaptation.

With a 24-hour half-life, MK-677 requires only once-daily dosing. Many users prefer bedtime administration to align with nocturnal growth hormone secretion and reduce daytime appetite stimulation. Morning dosing is pharmacokinetically equivalent.

Off-Cycle Duration

After 8-20 weeks of use, a 4-6 week break supports normalization of metabolic markers. This allows insulin sensitivity to recover and may prevent receptor desensitization.

Animal studies suggest that prolonged MK-677 administration increases hypothalamic somatostatin expression, which inhibits growth hormone release. Human studies have not consistently shown desensitization within standard cycle lengths. Periodic breaks remain a conservative safeguard.

Why Post-Cycle Therapy Isn’t Required

Traditional PCT exists to restart suppressed hormone production. MK-677 does not trigger the suppression that necessitates this intervention.

No Testosterone Suppression

Anabolic steroids suppress gonadotropin-releasing hormone, luteinizing hormone, and follicle-stimulating hormone. This shuts down testicular testosterone synthesis. PCT medications are required to reverse this cascade.

MK-677 does not bind androgen receptors or aromatize to estrogen. The HPG axis remains functional. Testosterone levels remain stable throughout use and after discontinuation.

Rapid Hormonal Normalization

Studies show that MK-677’s effects are reversible, with hormone levels returning to baseline after discontinuation. Crossover trials used 14-21 day washout periods. This suggests normalization occurs within 2-3 weeks.

This rapid reversal confirms the absence of endocrine dependency.

Any reduction in fat-free mass after discontinuation reflects loss of anabolic stimulus, not hormonal dysfunction. Users do not experience the mood instability, fatigue, or sexual dysfunction typical of suppressive compound withdrawal.

Off-Cycle Support Strategies

While prescription PCT drugs are unnecessary, targeted support during off-cycle periods helps maintain metabolic health.

Metabolic Support Supplements

Growth hormone can reduce insulin sensitivity through increased lipolysis and free fatty acid flux.

In one 12-month study, several subjects developed impaired fasting glucose during treatment. This resolved after discontinuation.

Berberine (500 mg twice daily), N-acetylcysteine (600 mg twice daily), or inositol support glucose metabolism during and after cycles. These interventions address the primary off-cycle concern associated with MK-677.

Recovery and Hormonal Health

Magnesium glycinate (400 mg nightly) supports sleep and stress regulation. Vitamin D3 (4,000-5,000 IU daily) supports immune and endocrine health. Zinc (15-30 mg daily) supports normal testosterone and growth hormone synthesis.

Omega-3 fatty acids (2-3 g daily) provide cardiovascular and metabolic support. They help maintain gains achieved during the cycle.


💡PEPTIDE PICKS: MORE TO EXPLORE


Clinical Evidence on Body Composition and Recovery

Controlled trials provide insight into MK-677’s effects on lean mass, sleep, and metabolic markers.

Fat-Free Mass Increases

In a 12-month study using DXA and four-compartment modeling, the MK-677 group gained 1.1 kg of fat-free mass. The placebo group lost 0.5 kg. These gains reflected true increases in body cell mass.

Another study examining caloric restriction found that subjects taking 25 mg of MK-677 daily maintained a positive nitrogen balance. The placebo group experienced protein loss.

Sleep Architecture Improvements

In studies in both young and older adults, daily 25 mg MK-677 increased slow-wave sleep by approximately 50%. REM sleep increased by more than 20%. Reports of sleep disturbances dropped dramatically compared to placebo.

In elderly subjects, REM sleep increased nearly 50% with shorter REM latency. This amplifies nocturnal growth hormone secretion and recovery.

Bone Turnover Markers

A nine-week study of 105 older adults showed increases in osteocalcin and bone-specific alkaline phosphatase. Markers of bone resorption also increased. These findings suggest increased bone remodeling activity, which may precede longer-term structural benefits.

Comparison: MK-677 vs. Traditional PCT Compounds

AspectMK-677 Off-CycleTraditional PCT
Testosterone suppressionNoneSevere
PCT medications neededNoYes
Recovery duration7-10 days4-8 weeks
Off-cycle focusMetabolic healthHormonal restart
Risk of crashNoneHigh without PCT
Support supplementsBerberine, magnesium, vitamin DSERMs, AI, zinc

Safety and Contraindications

MK-677 requires monitoring of metabolic rather than gonadal parameters.

Metabolic Monitoring

Fasting glucose and hemoglobin A1C levels should be checked before starting and during every full cycle. Individuals with prediabetes or metabolic syndrome may require heightened monitoring.

Hyperglycemia documented in case reports resolved after discontinuation. Blood pressure and fluid retention must also be monitored. Growth hormone increases intracellular water through renin-angiotensin-aldosterone signaling.

Cardiovascular Considerations

Ibutamoren carries warnings for heart failure risk in susceptible individuals. One clinical trial ended early due to cardiac concerns. Those with existing heart disease or significant hypertension should avoid MK-677.

Contraindications

Avoid use in cases of active malignancy due to elevated IGF-1 signaling. Do not use if diagnosed with diabetes, advanced cardiovascular disease, or during pregnancy or breastfeeding. MK-677 remains investigational and is not FDA-approved.

Legal and Regulatory Status

MK-677 is prohibited under WADA regulations. It is listed by the Department of Defense as a banned substance. It is not approved as a dietary supplement. Sale for human consumption violates federal law.

Frequently Asked Questions

Do I need Clomid or Nolvadex after an MK-677 cycle?

No. MK-677 does not suppress testosterone or the HPG axis. Focus on metabolic support during your 4-6 week off-cycle.

How long does it take for growth hormone levels to normalize?

Growth hormone typically normalizes within 7-10 days. IGF-1 returns to baseline within one month.

Can MK-677 be run longer than 12 weeks?

Yes. Human studies demonstrate safety for up to 24 months. Most users still cycle 8-20 weeks on, 4-6 weeks off.

Will gains disappear after stopping?

Lean mass may decline if training stops. Continued resistance training, adequate protein intake, and sleep help preserve gains off-cycle.

References

  1. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9):601-611. https://pmc.ncbi.nlm.nih.gov/articles/PMC2757071/
  2. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320-325. https://pubmed.ncbi.nlm.nih.gov/9467534/
  3. Effect of the orally active growth hormone secretagogue MK-677 on somatic growth in rats. J Endocrinol. 2018;239(2):111-122. https://pmc.ncbi.nlm.nih.gov/articles/PMC6240568/
  4. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. J Clin Endocrinol Metab. 1997;82(10):3232-3239. https://pubmed.ncbi.nlm.nih.gov/9349662/
  5. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. J Bone Miner Res. 1999;14(7):1182-1188. https://pubmed.ncbi.nlm.nih.gov/10404019/
  6. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med. 2008;149(9):601-611. https://pubmed.ncbi.nlm.nih.gov/18981485/

Keep Reading:

Get Peptide Science Without the Hype.

Join thousands getting accurate, research-backed peptide information from medical professionals.
Â